Plaque psoriasis is a chronic immune-driven skin condition that causes thick, raised patches of inflamed skin covered in silvery-white scales. It accounts for roughly 80% to 90% of all psoriasis cases, making it by far the most common form. The patches typically itch or burn and tend to appear in symmetrical patterns on both sides of the body.
What Happens in the Skin
In healthy skin, cells in the outermost layer replace themselves on a roughly 28-day cycle. Old cells shed invisibly, new cells rise to the surface, and the process stays in balance. In plaque psoriasis, the immune system sends faulty signals that dramatically speed up this cycle. Cells in the deepest layer of the skin divide every 1.5 days instead of the usual pace, and new cells reach the surface in as little as 3 to 7 days.
The skin simply can’t shed that fast. Dead cells pile up on the surface, forming the characteristic thick, silvery scales. Meanwhile, increased blood flow to the area creates the redness and inflammation underneath. This isn’t a skin problem at its root. It’s an immune system problem that shows up on the skin.
Where Plaques Appear
The elbows and knees are the most classic locations, but plaques also commonly develop on the scalp, trunk, palms, and soles of the feet. Many people notice patches on the lower back or around the hairline. The symmetrical pattern is a distinguishing feature: if a plaque appears on your right elbow, one often shows up on the left as well.
Scalp psoriasis can range from mild flaking that resembles dandruff to thick, crusted plaques that extend beyond the hairline onto the forehead or behind the ears. Plaques on the palms and soles can crack and bleed, making everyday tasks painful.
What Plaques Look and Feel Like
On lighter skin tones, plaques appear as raised, red patches topped with silvery-white scales. On darker skin tones, the patches may look more purple or dark brown, and the scales can appear gray. The borders of each plaque are usually well defined, with a clear edge separating affected skin from unaffected skin. Plaques can be round, oval, or irregular in shape.
If you gently scrape away the scale, you may see tiny pinpoint spots of bleeding underneath. This is called the Auspitz sign, and it’s one of the hallmarks doctors recognize during a clinical exam. Plaques can also develop at the site of a skin injury (a cut, scrape, sunburn, or even a tattoo), a response known as the Koebner phenomenon. This typically appears 10 to 14 days after the injury.
Common Triggers for Flare-Ups
Psoriasis tends to cycle between periods of active flares and relative calm. Several well-established triggers can set off or worsen a flare:
- Stress: One of the most frequently reported triggers, likely because stress hormones amplify the immune signals driving the disease.
- Skin injuries: Cuts, scrapes, bug bites, sunburns, shaving nicks, tattoos, and piercings can all provoke new plaques at the wound site about 10 to 14 days later.
- Cold, dry weather: Low humidity and dropping temperatures tend to worsen plaques, which is why many people experience their worst flares in winter.
- Infections: Strep throat, earaches, and bronchitis can trigger a flare 2 to 6 weeks after the infection.
- Certain medications: Lithium, antimalarials, some blood pressure drugs, and stopping strong corticosteroids abruptly can provoke flares, typically 2 to 3 weeks after starting or stopping the medication.
- Alcohol and smoking: Heavy drinking can reduce the effectiveness of psoriasis treatments significantly. Smoking is also linked to unexpected flare-ups and more severe disease overall.
How It’s Diagnosed
Plaque psoriasis is a clinical diagnosis, meaning a doctor can usually identify it by examining your skin. The combination of well-defined borders, silvery scale, symmetrical placement, and typical locations like elbows and knees gives a clear picture without needing lab work. A skin biopsy is generally unnecessary for classic presentations.
A biopsy may come into play when the presentation is unusual or when other conditions need to be ruled out. Plaque psoriasis can be mistaken for eczema, fungal infections, or other inflammatory skin conditions. Psoriasis on the palms and soles, for instance, can resemble contact dermatitis or lichen planus, and a biopsy helps sort that out when the clinical picture isn’t clear.
Measuring Severity
Doctors classify psoriasis as mild, moderate, or severe based on how much body surface area is affected and how much the condition impacts daily life. One widely used tool is the PASI score, which evaluates four body regions (head, arms, trunk, and legs) based on redness, thickness, and scaling. Each factor is graded on a 0 to 4 scale, with the legs weighted most heavily since they represent the largest skin area.
In practical terms, mild psoriasis covers less than 3% of your body (roughly the area of your two palms), moderate covers 3% to 10%, and severe covers more than 10%. But severity isn’t only about surface area. Plaques on highly visible areas like the face or hands, or on the genitals, can have an outsized impact on quality of life even when total coverage is small.
Treatment for Mild to Moderate Cases
Most people with limited plaque psoriasis start with topical treatments applied directly to the skin. Corticosteroid creams and ointments are the most commonly prescribed option, available in a range of strengths. Mild versions like hydrocortisone work well for sensitive areas such as the face or skin folds, while stronger formulations are used on thicker plaques. These are typically applied once daily during flares and less frequently during calmer periods.
Synthetic vitamin D creams are another first-line option. They work by slowing down the rapid skin cell turnover that creates plaques. These can be used alone or combined with a corticosteroid for better results. For scalp psoriasis specifically, medicated shampoos, foams, and scalp solutions deliver treatment through the hair to reach the skin underneath.
Treatment for Moderate to Severe Cases
When topical treatments aren’t enough, or when psoriasis covers a large area, treatment shifts to therapies that work from the inside out. Light therapy (phototherapy) uses controlled doses of ultraviolet light to slow cell turnover and reduce inflammation.
For more severe cases, biologic medications have transformed treatment over the past two decades. There are now 11 FDA-approved biologics for psoriasis, and they work by targeting specific parts of the immune system that drive the disease. The main classes include drugs that block TNF-alpha (a broad inflammatory signal), drugs that block IL-17 (a protein closely tied to skin inflammation), and drugs that block IL-23 (a protein that activates the immune cells responsible for psoriasis). The newer IL-17 and IL-23 inhibitors tend to produce higher rates of skin clearance than older options. These medications are given as injections or infusions, with dosing schedules ranging from every two weeks to every three months depending on the drug.
The Link to Psoriatic Arthritis
Between 7% and 26% of people with psoriasis eventually develop psoriatic arthritis, a condition where the same immune dysfunction that attacks the skin also attacks the joints. In most cases, skin symptoms come first. One large study of over 1,100 patients with psoriatic arthritis found that skin plaques appeared an average of 12 years before joint symptoms began.
Early signs of psoriatic arthritis include morning stiffness lasting more than 30 minutes, swollen fingers or toes (sometimes called “sausage digits”), and pain in the lower back, heels, or tendons. Joint damage from psoriatic arthritis can be permanent if left untreated, so persistent joint pain or stiffness in someone with plaque psoriasis is worth bringing up early. Several biologic medications are approved for both conditions, which means a single treatment can address skin and joint symptoms together.